Ebos Group (NZSE:EBO) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NZSE:EBO Ebos Group Ltd NZSE:EBO
92 GF Score
Price NZ$19.66
GF Value NZ$38.31
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Ebos Group FFO per Share?

FFO per Share only applies to REITs.

NZSE:EBO
92GF Score
Ebos Group Ltd NZSE:EBO
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ebos Group (NZSE:EBO) Overvalued in 2026?

Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued. The current stock price of NZ$19.66 is trading 48.7% below its estimated GF Value™ of NZ$38.31. GuruFocus considers Ebos Group to be Significantly Undervalued.

Key valuation signals for NZSE:EBO:

  • FFO per Share:
  • GF Value™: NZ$38.31 vs. price of NZ$19.66 (48.7% below fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the NZSE:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ebos Group Business Description

Address 737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008
Ebos Group Ltd is a healthcare and animal care products distributor operating primarily in Australia and New Zealand. Its core business is pharmaceutical wholesaling, supplying community pharmacies and hospitals under Australia's Pharmaceutical Benefits Scheme, which regulates drug pricing and wholesale margins. The company also operates an animal health segment that wholesales, manufactures, and retails veterinary products, along with third-party logistics services. Beyond distribution, Ebos provides pharmacy retail support and medical technology products. Community pharmacy customers represent the largest revenue contributor, followed by hospitals, while the animal health and logistics operations, though smaller, generate higher margins due to less regulatory oversight. The company generates revenue through wholesale distribution agreements, product sales, and service fees, with its geographic focus concentrated in the Australasian region.
92GF Score

Get the complete analysis for NZSE:EBO

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$19.66
Price
NZ$38.31
GF Value